These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 998364)

  • 1. Behavioral and pharmacological treatments for obesity: an experimental comparison.
    Ost LG; Götestam KG
    Addict Behav; 1976; 1(4):331-8. PubMed ID: 998364
    [No Abstract]   [Full Text] [Related]  

  • 2. A three year follow-up of a behavioral treatment for obesity.
    Götestam KG
    Addict Behav; 1979; 4(2):179-83. PubMed ID: 474267
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of fenfluramine (with ad libitum food intake) with 1,000 calorie diet in obesity.
    Hooper AC
    J Ir Med Assoc; 1972 Jan; 65(2):35-7. PubMed ID: 5058787
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term weight control study. IV (weeks 156 to 190). The second double-blind phase.
    Weintraub M; Sundaresan PR; Schuster B; Averbuch M; Stein EC; Cox C; Byrne L
    Clin Pharmacol Ther; 1992 May; 51(5):608-14. PubMed ID: 1587075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary and medical treatments of obesity: an evaluative review.
    Chlouverakis C
    Addict Behav; 1975 Jul; 1(1):3-21. PubMed ID: 1234706
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of obesity with fenfluramine (Ponderal)].
    Persson I; Andersen UD; Deckert T
    Ugeskr Laeger; 1973 Sep; 135(36):1932-7. PubMed ID: 4590075
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
    Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
    Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise.
    Weintraub M; Sundaresan PR; Schuster B; Ginsberg G; Madan M; Balder A; Stein EC; Byrne L
    Clin Pharmacol Ther; 1992 May; 51(5):595-601. PubMed ID: 1587073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenfluramine in the treatment of obesity.
    Stunkard A; Rickels K; Hesbacher P
    Lancet; 1973 Mar; 1(7802):503-5. PubMed ID: 4119946
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind clinical trial of fenfluramine in the treatment of obesity.
    Sainani GS; Fulambarkar AM; Khurana BK
    Br J Clin Pract; 1973 Apr; 27(4):136-8. PubMed ID: 4586636
    [No Abstract]   [Full Text] [Related]  

  • 11. Fenfluramine in the management of obesity.
    Datey KK; Kelkar PN; Pandya RS
    Br J Clin Pract; 1973 Oct; 27(10):373-5. PubMed ID: 4601613
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of obesity with fenfluramine.
    Persson I; Andersen U; Deckert T
    Eur J Clin Pharmacol; 1973 Aug; 6(2):93-7. PubMed ID: 4588854
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine.
    Weintraub M; Sundaresan PR; Schuster B; Moscucci M; Stein EC
    Clin Pharmacol Ther; 1992 May; 51(5):602-7. PubMed ID: 1587074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind cross-over study of fenfluramine (Ponderax) in obesity.
    Rastogi GK; Sharma PL; Saini GS; Kanen VL
    J Assoc Physicians India; 1972 Nov; 20(11):849-52. PubMed ID: 4570012
    [No Abstract]   [Full Text] [Related]  

  • 15. Weight control programs.
    Stern JS
    Curr Concepts Nutr; 1977; 5():137-55. PubMed ID: 322948
    [No Abstract]   [Full Text] [Related]  

  • 16. [The therapeutic effect of Fenfluramine on body weight in overweight patients. A controlled clinical study].
    Haug E; Myklebust R
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2545-9. PubMed ID: 4589598
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of obesity with fenfluramine.
    Schindler H; Bielesz G
    Wien Med Wochenschr; 1975 Jan; 125(5):85-8. PubMed ID: 1124579
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioural management of obesity.
    Stunkard AJ
    Med J Aust; 1985 Apr; 142(SP7):S13-20. PubMed ID: 3884985
    [No Abstract]   [Full Text] [Related]  

  • 19. [Psychiatric complications in the treatment of obesity using fenfluramine].
    Klompenhouwer JL; Stricker BH; van Tilburg AJ; Moleman P; Pepplinkhuizen L
    Ned Tijdschr Geneeskd; 1988 Nov; 132(46):2114-7. PubMed ID: 3205320
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavior therapy and pharmacotherapy for obesity.
    Craighead LW; Stunkard AJ; O'Brien RM
    Arch Gen Psychiatry; 1981 Jul; 38(7):763-8. PubMed ID: 7247639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.